59101-27-8

Basic information

• Product Name: 15-BROMO-1-PENTADECANOL
• Synonyms: 15-BROMO-1-PENTADECANOL;15-BROMO-PENTADECAN-1-OL;VITAS-BB TBB000205;1-Pentadecanol, 15-broMo-
• CAS NO: 59101-27-8
• Molecular Formula: C₁₅H₃₁BrO
• Molecular Weight: 307.31
• Product Categories: CMLLYL
• Mol File: 59101-27-8.mol
• Article Data: 13

Chemical Properties

• Melting Point: 63.6-64.1 °C
• Boiling Point: 368.9 °C at 760 mmHg
• Flash Point: 133 °C
• Appearance: /
• Density: 1.071 g/cm³
• Vapor Pressure: 6.09E-07mmHg at 25°C
• Refractive Index: 1.475
• Storage Temp.: 2-8°C
• PKA: 15.20±0.10(Predicted)
• CAS DataBase Reference: 15-BROMO-1-PENTADECANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 15-BROMO-1-PENTADECANOL(59101-27-8)
• EPA Substance Registry System: 15-BROMO-1-PENTADECANOL(59101-27-8)

Safety Data

• Hazardous Substances Data: 59101-27-8(Hazardous Substances Data)

Usage

General Description

15-BROMO-1-PENTADECANOL is a chemical compound with a molecular formula of C15H31BrO. It is a long-chain primary aliphatic alcohol with a bromine atom attached to the 15th carbon. 15-BROMO-1-PENTADECANOL is used in organic synthesis and as a precursor for the production of various other organic compounds. It has the potential to be used as a surfactant or emulsifier in cosmetic and personal care products due to its long carbon chain, and it may also have applications in the field of pharmaceuticals and agrochemicals. This chemical may have health and environmental hazards, and appropriate safety measures should be taken when handling and using it.

InChI:InChI=1/C15H31BrO/c16-14-12-10-8-6-4-2-1-3-5-7-9-11-13-15-17/h17H,1-15H2

Upstream product

• 14722-40-8 1,15-pentadecanediol 
• 10035-10-6 hydrogen bromide 
• 869734-95-2 methyl 15-((methylsulfonyl)oxy)pentadecanoate 
• 106-02-5 pentadecanolide 
• 1460-18-0 pentadecanedioic acid 
• 76529-42-5 methyl 15-hydroxypentadecanoate 
• 41240-56-6 15-bromopentadecanoic acid methyl ester 
• 101592-34-1 15-bromo-ethyl-pentadecanoate 
• 56523-59-2 15-bromo-pentadecanoic acid 
• 16346-16-0 pentadec-14-en-1-ol 
• 871888-39-0 1,15-dimethoxy-pentadecane 

Downstream Products

• 36645-68-8 triacontane-1,30-diol 
• 132910-90-8 (15-bromopentadecyloxy)(tert-butyl)diphenylsilane 
• 1391985-80-0 17-(tert-butyldiphenylsilyloxy)-N-methoxy-N-methyl-2-(prop-1-en-2-yl)heptadecanamide 
• 1391985-72-0 tert-butyl(15-iodopentadecyloxy)diphenylsilane 

Relevant articles and documents

A simple technique to grow polymer brushes using in situ surface ligation of an organometallic initiator

A simple approach is described here for the in-place synthesis of polymer brushes by surface-initiated polymerization. A cyano-terminated self-assembled monolayer on a gold surface was used to anchor a highly active cationic Pd organometallic initiator by ligand exchange. We grew ultrasmooth patterned poly(4-methoxystyrene) brushes with excellent thickness control at room temperature. Copyright

Synthesis of [3]rotaxanes that utilize the catalytic activity of a macrocyclic phenanthroline-Cu complex: Remarkable effect of the length of the axle precursor

[3]Rotaxanes, which consist of one macrocyclic phenanthroline compound and two axle components, were prepared by the oxidative dimerization of an alkyne compound with bulky tris[4'-cyclohexyl-(1,1'-biphenyl)-4-yl]methyl blocking group. The catalytic activ

Synthesis of new ligands for targeting the S1P1 receptor

Sphingosine-1-phosphate (S1P) influences various fundamental biological processes by interacting with a family of five G protein-coupled receptors (S1P1-5). FTY720, a sphingosine analogue, which was approved for treatment of relapsing forms of multiple sclerosis, is phosphorylated in vivo and acts as an agonist of four of the five S1P receptor subtypes. Starting from these lead structures we developed new agonists for the S1P1 receptor. The biological activity was tested in vivo and promising ligands were fluorinated at different positions to identify candidates for positron emission tomography (PET) imaging after [18F]-labelling. The radioligands shall enable the imaging of S1P1 receptor expression in vivo and thus may serve as novel imaging markers of S1P-related diseases.